Vimarsana
Biggest News Aggregation in the World

Assessing Registries News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Assessing Registries. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Assessing Registries Today - Breaking & Trending Today

Realizing the Promise of Real-World Evidence - Vimarsana News

Realizing the Promise of Real-World Evidence

Realizing the full potential of RWE in regulatory decision-making presents several challenges, and work is underway at the FDA to better understand this area.

Source: fda.gov
New FDA electronic records guidance prioritizes Digital Health Technology oversight - Vimarsana News

New FDA electronic records guidance prioritizes Digital Health Technology oversight

On March 15, the U.S. Food and Drug Administration (FDA) issued revised draft guidance summarizing how it intends regulate the use of electronic…

New FDA electronic records guidance prioritizes Digital Health Technology oversight | Hogan Lovells - Vimarsana News

New FDA electronic records guidance prioritizes Digital Health Technology oversight | Hogan Lovells

On March 15, the U.S. Food and Drug Administration (FDA) issued revised draft guidance summarizing how it intends regulate the use of electronic systems, records, and signatures in...

Next-Generation Rett Syndrome Global Registry Designed to Unify Disparate Patient Data to Support Clinical Development Receives Positive Feedback from FDA - Vimarsana News

Next-Generation Rett Syndrome Global Registry Designed to Unify Disparate Patient Data to Support Clinical Development Receives Positive Feedback from FDA

Trumbull, CT (PRWEB) January 18, 2022 -- The innovative Rett Syndrome Global Registry presented to the Food and Drug Administration (FDA) was met with

Source: prweb.com
FDA RWD/RWE regulatory considerations in draft guidance highlight opportunities and challenges - Laying groundwork for high-quality evidence to support regulatory decisions | Hogan Lovells - Vimarsana News

FDA RWD/RWE regulatory considerations in draft guidance highlight opportunities and challenges - Laying groundwork for high-quality evidence to support regulatory decisions | Hogan Lovells

This month, FDA released the latest in a series of agency guidance to advance the development and use of real-world data (RWD) and real-world evidence (RWE) in clinical trial designs...